Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 3

Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time

Authors Ly T, Gulia J, Pyrgos V, Waga M, Shoham S

Published 6 June 2008 Volume 2008:4(3) Pages 637—640


Tam Ly, Jyoti Gulia, Vasilios Pyrgos, Masashi Waga, Shmuel Shoham

Section of Infectious Diseases, Washington Hospital Center, Washington DC, USA

Abstract: Fluorescence in situ hybridization using peptide nucleic acid probes (PNA-FISH) differentiates Staphylococcus aureus from other Gram-positive-cocci in clusters (GPCC). 101/202 patients with GPCC+ blood cultures were randomly assigned to clinician-notification of PNA FISH results. Notifi cation was associated with reduced mortality (8% vs.17%, p = 0.05), further antibiotic use (median −2.5 days, p = 0.01), and trended toward reduced hospital stay and charges.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Unusual case of contralateral Horner's syndrome following stellate-ganglion block: a case report and review of the literature

Amhaz HH, Manders L, Chidiac EJ, Pallekonda V, Chakrabortty S

Local and Regional Anesthesia 2013, 6:31-33

Published Date: 10 October 2013

Lung function decline in COPD

Tantucci C, Modina D

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:95-99

Published Date: 9 February 2012

Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil

Divaldo Pereira de Lyra Júnior, Nadir Kheir, Juliana Palma Abriata, Chiara Ermínia da Rocha, Cláudia Benedita dos Santos, et al

Therapeutics and Clinical Risk Management 2007, 3:989-998

Published Date: 15 January 2008

Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction

James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson et al

Therapeutics and Clinical Risk Management 2007, 3:975-981

Published Date: 15 January 2008

The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression

Savvas Diafas, Douglas G Day, Jeanette A Stewart, William C Stewart

Therapeutics and Clinical Risk Management 2007, 3:725-732

Published Date: 15 November 2007

Editorial Foreword || FREE PAPER ||

Garry M Walsh

Therapeutics and Clinical Risk Management 2007, 3:705-706

Published Date: 15 November 2007

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Shimon Lecht, Simon Haroutiunian, Amnon Hoffman, Philip Lazarovici

Therapeutics and Clinical Risk Management 2007, 3:467-474

Published Date: 15 July 2007